TY  - JOUR

T1  - 454 A phase II study of vinorebline (VRL) alterning oral and intravenous (IV) plus epirubicin (EPI) as first line chemotherapy of metastatic breast cancer (MBC)

JO  - European Journal of Cancer Supplements

PY  - 2003/09/01

AU  - Verrill M

AU  - Serin D

AU  - Jones A

AU  - Delozier T

AU  - Coleman R

ED  - 

DO  - DOI: 10.1016/s1359-6349(03)90486-1

PB  - Elsevier BV

VL  - 1

IS  - 5

SP  - S138

EP  - S139

Y2  - 2025/10/10

ER  -